Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1899 1
1933 1
1941 1
1943 1
1944 1
1946 2
1949 3
1950 3
1951 2
1952 1
1953 2
1954 2
1955 1
1957 3
1958 1
1960 2
1961 2
1962 2
1963 1
1964 1
1965 3
1966 2
1967 1
1968 1
1969 5
1970 3
1971 3
1972 1
1973 5
1974 6
1975 9
1976 11
1977 4
1978 4
1979 6
1980 5
1981 4
1982 6
1983 2
1984 6
1985 6
1986 6
1987 8
1988 5
1989 6
1990 3
1991 6
1992 6
1993 4
1994 1
1995 5
1996 5
1997 4
1998 2
1999 5
2000 3
2001 8
2002 2
2003 2
2004 4
2005 2
2006 1
2007 9
2008 10
2009 10
2010 15
2011 13
2012 19
2013 18
2014 26
2015 33
2016 37
2017 22
2018 31
2019 26
2020 25
2021 26
2022 34
2023 26
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

545 results

Results by year

Filters applied: . Clear all
Page 1
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial.
Han JK, Bachert C, Fokkens W, Desrosiers M, Wagenmann M, Lee SE, Smith SG, Martin N, Mayer B, Yancey SW, Sousa AR, Chan R, Hopkins C; SYNAPSE study investigators. Han JK, et al. Among authors: smith sg. Lancet Respir Med. 2021 Oct;9(10):1141-1153. doi: 10.1016/S2213-2600(21)00097-7. Epub 2021 Apr 16. Lancet Respir Med. 2021. PMID: 33872587
Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count.
Bachert C, Sousa AR, Han JK, Schlosser RJ, Sowerby LJ, Hopkins C, Maspero JF, Smith SG, Kante O, Karidi-Andrioti DE, Mayer B, Chan RH, Yancey SW, Chaker AM. Bachert C, et al. Among authors: smith sg. J Allergy Clin Immunol. 2022 May;149(5):1711-1721.e6. doi: 10.1016/j.jaci.2021.10.040. Epub 2022 Jan 7. J Allergy Clin Immunol. 2022. PMID: 35007624 Free article. Clinical Trial.
Genetically Defined Syngeneic Mouse Models of Ovarian Cancer as Tools for the Discovery of Combination Immunotherapy.
Iyer S, Zhang S, Yucel S, Horn H, Smith SG, Reinhardt F, Hoefsmit E, Assatova B, Casado J, Meinsohn MC, Barrasa MI, Bell GW, Pérez-Villatoro F, Huhtinen K, Hynninen J, Oikkonen J, Galhenage PM, Pathania S, Hammond PT, Neel BG, Farkkila A, Pépin D, Weinberg RA. Iyer S, et al. Among authors: smith sg. Cancer Discov. 2021 Feb;11(2):384-407. doi: 10.1158/2159-8290.CD-20-0818. Epub 2020 Nov 6. Cancer Discov. 2021. PMID: 33158843 Free PMC article.
Structural features and inhibitors of bromodomains.
Meslamani J, Smith SG, Sanchez R, Zhou MM. Meslamani J, et al. Among authors: smith sg. Drug Discov Today Technol. 2016 Mar;19:3-15. doi: 10.1016/j.ddtec.2016.09.001. Epub 2016 Sep 22. Drug Discov Today Technol. 2016. PMID: 27769355 Free PMC article. Review.
Mepolizumab Reduces Systemic Corticosteroid Use in Chronic Rhinosinusitis With Nasal Polyps.
Chupp G, Alobid I, Lugogo NL, Kariyawasam HH, Bourdin A, Chaker AM, Smith SG, Sousa AR, Mayer B, Chan RH, Matucci A. Chupp G, et al. Among authors: smith sg. J Allergy Clin Immunol Pract. 2023 Nov;11(11):3504-3512.e2. doi: 10.1016/j.jaip.2023.08.015. Epub 2023 Aug 14. J Allergy Clin Immunol Pract. 2023. PMID: 37586475 Free article. Clinical Trial.
Discovery of Chemical Inhibitors of Human Bromodomains.
Zhang G, Smith SG, Zhou MM. Zhang G, et al. Among authors: smith sg. Chem Rev. 2015 Nov 11;115(21):11625-68. doi: 10.1021/acs.chemrev.5b00205. Epub 2015 Oct 23. Chem Rev. 2015. PMID: 26492937 Review. No abstract available.
545 results